Axsome Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Axsome Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2015 to Q1 2024.
  • Axsome Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $132K, a 46.7% increase year-over-year.
  • Axsome Therapeutics, Inc. annual Depreciation for 2023 was $459K, a 74.5% increase from 2022.
  • Axsome Therapeutics, Inc. annual Depreciation for 2022 was $263K, a 246% increase from 2021.
  • Axsome Therapeutics, Inc. annual Depreciation for 2021 was $76K, a 218% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $132K +$42K +46.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q1 2023 $90K +$53K +143% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q1 2022 $37K +$28.7K +344% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $8.33K +$2.89K +53.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-02
Q1 2020 $5.44K -$6K -52.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $11.4K -$499 -4.18% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $11.9K +$1.83K +18% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $10.1K +$8K +379% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q1 2016 $2.11K +$1.81K +595% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q1 2015 $304 Jan 1, 2015 Mar 31, 2015 10-Q/A 2016-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.